CHARLOTTE, N.C. — ParinGenix, a pharmaceutical startup in Charlotte, has raised $5.92 million in a B round of financing, according to Private Equity Wire.

ParinGenix plans to raise $20.4 million, PE Wire reported, citing a regulatory filing.

ParinGenix is developing drugs based on a form of Herapin, an anticoagulant.

Investors include Academy Venture Fund of Charlotte, Research Corporation Technologies and A.P. Kennedy Family Securities.

The company was founded in 2002 by Thomas Kennedy, a doctor at Carolinas Medical Center.